Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Other companies in Aprea Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Nanoviricides (AMEX:NNVC) and Bolt Biotherapeutics (NASDAQ:BOLT).
Aprea Therapeutics has a consensus price target of $10.60.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $3.49 last updated February 18, 2025 at 4:00 PM EST.
There are no upcoming dividends for Aprea Therapeutics.
Aprea Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Aprea Therapeutics.
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.